Catalog # |
Size |
Price |
|
---|---|---|---|
019-16 | 200 µg | $97 |
Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2
|
3826.43 | |
| ≥ 95% |
| Exhibits correct molecular weight |
| Insoluble in water. Dissolve in 100-500 µl of 0.1M ammonium hydroxide or any other basic buffer ( pH > 9). |
|
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles. |
| White powder |
| Each vial contains 200 µg of NET peptide. |
In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: a role for opioid receptors.
Charron C, Fréchette S, Proulx G, Plamondon H. Behav Brain Res. 2008;188(1):125-35.
Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty.
Lebrethon MC, Aganina A, Fournier M, Gérard A, Parent AS, Bourguignon JP. J Neuroendocrinol. 2007;19(3):181-8.
Corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 are both trafficking and signaling receptors for urocortin.
Tu H, Kastin AJ, Pan W. Mol Endocrinol. 2007;21(3):700-11.
The CRH1 antagonist CP154,526 failed to alter ischemia-induced neurodegeneration and spatial memory deficits in rats but inhibited behavioral activity in the novel open field.
Plamondon H, Khan S. Behav Brain Res. 2006;166(1):85-92.
Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion.
Samson WK, Keown C, Samson CK, et al. Endocrine. 2003;20(1-2):59-66.
Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure.
Correia ML, Morgan DA, Mitchell JL, Sivitz WI, Mark AL, Haynes WG. Hypertension. 2001;38(3):384-8.
Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro.
Leitch IM, Boura AL, Botti C, Read MA, Walters WA, Smith R. J Clin Endocrinol Metab. 1998;83(12):4510-3.
Social Network Confirmation